Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection

NCT07491081 is registered in ClinicalTrials.gov with Queensland Centre for Gynaecological Cancer as lead sponsor.

NCT NCT07491081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07491081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection
Lead sponsor
Queensland Centre for Gynaecological Cancer
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2026
Completion date
December 31, 2030
Enrollment
1,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer